Valuation: LifeVantage Corporation

Market Cap 83.9M 73.69M 67.9M 63.49M 119M 7.92B 121M 815M 316M 3.9B 315M 308M 13.56B P/E 2026 *
15.8x
P/E 2027 * 17.1x
Enterprise Value 70.35M 61.79M 56.93M 53.23M 99.84M 6.64B 102M 683M 265M 3.27B 264M 258M 11.37B EV / Sales 2026 *
0.38x
EV / Sales 2027 * 0.39x
Free-Float
83.58%
Yield 2026 *
-
Yield 2027 * -
1 day+6.74%
1 week+3.74%
Current month-15.50%
1 month+18.54%
3 months+55.01%
6 months+5.06%
Current year+7.95%
1 week 5.8
Extreme 5.8
6.7
1 month 5.52
Extreme 5.52
11.71
Current year 3.9
Extreme 3.9
11.71
1 year 3.9
Extreme 3.9
15
3 years 3.9
Extreme 3.9
27.38
5 years 3.04
Extreme 3.04
27.38
10 years 2.86
Extreme 2.86
27.38
Manager TitleAgeSince
Chief Executive Officer 74 2026-04-29
Director of Finance/CFO 53 2021-10-24
Chief Tech/Sci/R&D Officer - 2026-01-06
Director TitleAgeSince
Director/Board Member 74 2011-12-31
Director/Board Member 67 2017-01-31
Director/Board Member 68 2022-02-16
Date Insider Type Main position Quantity % Market Cap.
06-14Buy

Director

705 0.0056%
06-02Sell

Chief Executive Officer

-10,000 0.0793%
03-31Tax

General Counsel

1,446 0.0113%
Change 5-day change 1-year change 3-year change Capi.($)
+6.74%+3.74%-47.18%+47.78% 83.9M
+0.93%+2.65%+42.33%+145.77% 1,006B
+1.61%+7.22%+60.81%+47.98% 589B
+3.51%+12.31%+31.15%+78.88% 430B
-1.46%+5.11%+29.26%+21.27% 331B
-0.90%+5.33%+37.42%+23.45% 288B
-1.83%+4.43%+28.66%+38.93% 285B
-2.53%+4.98%-28.63%-42.78% 213B
+0.40%+4.51%+25.85%+55.35% 190B
-1.05%+0.06%+16.91%+59.86% 154B
Average +0.07%+5.74%+19.66%+47.65% 348.58B
Weighted average by Cap. -0.33%+5.38%+34.95%+70.08%

Financials

2026 *2027 *
Net sales 184M 162M 149M 139M 261M 17.38B 266M 1.79B 693M 8.57B 692M 677M 29.77B 178M 157M 144M 135M 253M 16.83B 258M 1.73B 671M 8.3B 670M 655M 28.83B
Net income 5.3M 4.66M 4.29M 4.01M 7.52M 500M 7.66M 51.46M 19.93M 247M 19.9M 19.47M 857M 4.9M 4.3M 3.97M 3.71M 6.95M 462M 7.08M 47.58M 18.43M 228M 18.4M 18M 792M
Net Debt -13.55M -11.9M -10.97M -10.25M -19.23M -1.28B -19.58M -132M -50.96M -630M -50.88M -49.77M -2.19B -15M -13.17M -12.14M -11.35M -21.28M -1.41B -21.67M -146M -56.4M -697M -56.31M -55.08M -2.42B
Logo LifeVantage Corporation
LifeVantage Corporation is an activation company, which is engage in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, weight management products, pre- and pro-biotics, skin and hair care products, and nootropics. The Company’s line of scientifically validated activators includes the flagship Protandim family of products, TrueScience Liquid Collagen, the newest MindBody GLP-1 System, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System , as well as AXIO nootropic energy drink mixes, the full TrueScience line of skin and hair care products, and Petandim, a pet supplement formulated to combat oxidative stress in dogs. It sells its products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand and Singapore.
Employees
235
Date Price Change Volume
26-06-25 US$6.650 +6.74% 172,979
26-06-24 US$6.230 +0.81% 144,093
26-06-23 US$6.180 +1.64% 233,149
26-06-22 US$6.080 -5.15% 324,564
26-06-18 US$6.410 +5.78% 467,446
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
6.650USD
Average target price
7.000USD
Spread / Average Target
+5.26%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LFVN Stock